Shanghai Haohai Biological Technology financials at a glance

+ Portfolio

The revenue of Shanghai Haohai Biological Technology is reported as 2.63491 billion Dollars in the fiscal year 2023. The earnings were 0 Dollars per share in 2023, which was 58.97 higher than 2020. And about 0.2679 billion Dollars are reported as free cash flow in the financials of Shanghai Haohai Biological Technology 2023. Dividends of 1 Dollars per share were paid to shareholders of Shanghai Haohai Biological Technology stock SEHK:6826 in fiscal 2023.

Forecast

Financials

Year	Year	TTM	2021	2020	2019	2018	2017	2016	2015
Rev.	Revenue	N/A	HK$1.77B	HK$1.33B	HK$1.60B	HK$1.55B	HK$1.34B	HK$851.16M	HK$663.92M
GM %	Gross Margin %	70.25%	71.98%	74.78%	77.19%	78.37%	78.62%	83.37%	84.17%
OM	Operating Margin	12.20%	11.25%	6.91%	18.95%	24.50%	27.68%	33.41%	33.53%
EPS	Earnings Per Share	HK$2.02	HK$1.86	HK$1.17	HK$2.19	HK$2.60	HK$2.33	HK$1.91	HK$1.86
Div.	Dividends	N/A	HK$0.70	HK$0.50	HK$0.70	HK$0.50	HK$0.50	HK$0.50	HK$0.40
PR %	Payout Ratio %	0	37.63%	42.74%	31.96%	19.23%	21.46%	26.18%	21.51%
Sha.	Shares	N/AM	175.82M	176.62M	177.85M	160.05M	160.05M	160.05M	160.05M
OCF	Operating Cash Flow	N/A	HK$342.29M	HK$262.07M	HK$348.91M	HK$391.28M	HK$343.06M	HK$254.49M	HK$268.51M
FCF	Free Cash Flow	N/A	HK$71.41M	HK$72.37M	HK$99.73M	HK$240.07M	HK$208.77M	HK$178.82M	HK$198.40M
FCFS	Free Cash Flow Per Share	HK$0.58	HK$0.40	HK$0.37	HK$-0.31	HK$1.50	HK$1.30	HK$1.12	HK$1.35

Shanghai Haohai Biological Technology financials at a glance

Financials

Discover